DexCom Net Profit Margin 2010-2025 | DXCM
Current and historical net profit margin for DexCom (DXCM) from 2010 to 2025. Net profit margin can be defined as net Income as a portion of total sales revenue. DexCom net profit margin for the three months ending March 31, 2025 was .
| DexCom Net Profit Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM Net Income | Net Margin |
| 2025-03-31 | $4.15B | $0.54B | 12.92% |
| 2024-12-31 | $4.03B | $0.58B | 14.31% |
| 2024-09-30 | $3.95B | $0.68B | 17.22% |
| 2024-06-30 | $3.94B | $0.67B | 16.95% |
| 2024-03-31 | $3.80B | $0.64B | 16.81% |
| 2023-12-31 | $3.62B | $0.54B | 14.96% |
| 2023-09-30 | $3.40B | $0.38B | 11.11% |
| 2023-06-30 | $3.20B | $0.36B | 11.19% |
| 2023-03-31 | $3.02B | $0.29B | 9.69% |
| 2022-12-31 | $2.91B | $0.34B | 11.72% |
| 2022-09-30 | $2.79B | $0.24B | 8.74% |
| 2022-06-30 | $2.67B | $0.23B | 8.60% |
| 2022-03-31 | $2.57B | $0.26B | 9.99% |
| 2021-12-31 | $2.45B | $0.22B | 8.86% |
| 2021-09-30 | $2.32B | $0.63B | 27.30% |
| 2021-06-30 | $2.17B | $0.62B | 28.48% |
| 2021-03-31 | $2.03B | $0.59B | 28.91% |
| 2020-12-31 | $1.93B | $0.55B | 28.49% |
| 2020-09-30 | $1.82B | $0.23B | 12.69% |
| 2020-06-30 | $1.72B | $0.21B | 11.95% |
| 2020-03-31 | $1.60B | $0.15B | 9.25% |
| 2019-12-31 | $1.48B | $0.10B | 6.84% |
| 2019-09-30 | $1.35B | $-0.17B | -12.73% |
| 2019-06-30 | $1.22B | $-0.17B | -13.99% |
| 2019-03-31 | $1.13B | $-0.13B | -11.51% |
| 2018-12-31 | $1.03B | $-0.13B | -12.31% |
| 2018-09-30 | $0.92B | $0.04B | 4.81% |
| 2018-06-30 | $0.83B | $-0.01B | -0.60% |
| 2018-03-31 | $0.76B | $-0.03B | -4.20% |
| 2017-12-31 | $0.72B | $-0.05B | -6.95% |
| 2017-09-30 | $0.67B | $-0.05B | -7.17% |
| 2017-06-30 | $0.63B | $-0.07B | -10.27% |
| 2017-03-31 | $0.60B | $-0.09B | -14.69% |
| 2016-12-31 | $0.57B | $-0.07B | -11.34% |
| 2016-09-30 | $0.53B | $-0.06B | -10.51% |
| 2016-06-30 | $0.49B | $-0.08B | -16.36% |
| 2016-03-31 | $0.45B | $-0.06B | -14.38% |
| 2015-12-31 | $0.40B | $-0.06B | -14.43% |
| 2015-09-30 | $0.36B | $-0.06B | -16.62% |
| 2015-06-30 | $0.32B | $-0.02B | -6.58% |
| 2015-03-31 | $0.29B | $-0.02B | -8.07% |
| 2014-12-31 | $0.26B | $-0.02B | -8.88% |
| 2014-09-30 | $0.23B | $-0.03B | -11.89% |
| 2014-06-30 | $0.20B | $-0.03B | -13.93% |
| 2014-03-31 | $0.18B | $-0.03B | -17.98% |
| 2013-12-31 | $0.16B | $-0.03B | -18.63% |
| 2013-09-30 | $0.14B | $-0.04B | -24.65% |
| 2013-06-30 | $0.12B | $-0.05B | -37.70% |
| 2013-03-31 | $0.11B | $-0.05B | -46.79% |
| 2012-12-31 | $0.10B | $-0.05B | -54.55% |
| 2012-09-30 | $0.09B | $-0.06B | -65.91% |
| 2012-06-30 | $0.08B | $-0.05B | -65.06% |
| 2012-03-31 | $0.08B | $-0.05B | -56.79% |
| 2011-12-31 | $0.08B | $-0.04B | -58.67% |
| 2011-09-30 | $0.07B | $-0.04B | -60.87% |
| 2011-06-30 | $0.06B | $-0.04B | -66.67% |
| 2011-03-31 | $0.05B | $-0.05B | -87.04% |
| 2010-12-31 | $0.05B | $-0.06B | -110.00% |
| 2010-09-30 | $0.04B | $-0.06B | -129.55% |
| 2010-06-30 | $0.04B | $-0.06B | -148.72% |
| 2010-03-31 | $0.03B | $-0.06B | -179.41% |
| 2009-12-31 | $0.03B | $-0.05B | -186.21% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $33.459B | $4.033B |
| DexCom, Inc. is a medical device company focused on the design, development and commercialization of continuous glucose monitoring systems (CGM). These are for ambulatory use by people with diabetes and by healthcare providers for the treatment of diabetic and non-diabetic patients. A key element of DexCom's monitoring system technology is the continuous measure of patient's blood glucose level and transmission of that information to a small cell phone-sized receiver in real time. The company's monitoring systems aim to provide real-time continuous blood glucose values, trend data and alerts to assist patients in managing their blood glucose levels. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Intuitive Surgical (ISRG) | United States | $185.102B | 81.07 |
| Thermo Fisher Scientific (TMO) | United States | $160.563B | 19.42 |
| Edwards Lifesciences (EW) | United States | $45.919B | 30.11 |
| Alcon (ALC) | Switzerland | $43.070B | 29.11 |
| IDEXX Laboratories (IDXX) | United States | $42.738B | 49.12 |
| IQVIA Holdings (IQV) | United States | $27.702B | 15.52 |
| Mettler-Toledo (MTD) | United States | $24.812B | 29.51 |
| STERIS (STE) | Ireland | $22.211B | 24.46 |
| Waters (WAT) | United States | $18.101B | 25.54 |
| SONOVA HOLDING (SONVY) | Switzerland | $17.184B | 0.00 |
| Hologic (HOLX) | United States | $14.400B | 15.65 |
| Sysmex ADR (SSMXY) | Japan | $10.569B | 29.98 |
| Penumbra (PEN) | United States | $9.268B | 72.74 |
| Masimo (MASI) | United States | $8.767B | 32.34 |
| Globus Medical (GMED) | United States | $7.767B | 18.51 |
| Glaukos (GKOS) | United States | $5.953B | 0.00 |
| Teleflex (TFX) | United States | $5.115B | 8.44 |
| Integer Holdings (ITGR) | United States | $4.169B | 21.84 |
| TransMedics (TMDX) | United States | $3.953B | 85.94 |
| PROCEPT BioRobotics (PRCT) | United States | $3.218B | 0.00 |
| LivaNova (LIVN) | United Kingdom | $2.398B | 14.28 |
| Nihon Kohden (NHNKY) | Japan | $2.099B | 24.07 |
| Veracyte (VCYT) | United States | $2.087B | 29.29 |
| Elekta AB (EKTAY) | Sweden | $1.903B | 17.10 |
| Alphatec Holdings (ATEC) | United States | $1.595B | 0.00 |
| Artivion (AORT) | United States | $1.353B | 126.72 |
| Pulse Biosciences (PLSE) | United States | $1.081B | 0.00 |
| OPKO Health (OPK) | United States | $1.063B | 0.00 |
| Tandem Diabetes Care (TNDM) | United States | $1.049B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $0.949B | 5.05 |
| IRadimed (IRMD) | United States | $0.738B | 37.47 |
| SiBone (SIBN) | United States | $0.738B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.619B | 13.42 |
| Beta Bionics (BBNX) | United States | $0.556B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.548B | 8.53 |
| AxoGen (AXGN) | United States | $0.547B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.538B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.456B | 10.60 |
| Pacific Biosciences Of California (PACB) | United States | $0.438B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.430B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.413B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.391B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.377B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.332B | 0.00 |
| RxSight (RXST) | United States | $0.315B | 0.00 |
| NeuroPace (NPCE) | United States | $0.313B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.274B | 0.00 |
| Neuronetics (STIM) | United States | $0.255B | 0.00 |
| 908 Devices (MASS) | United States | $0.241B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.233B | 14.14 |
| Monogram Orthopaedics (MGRM) | United States | $0.209B | 0.00 |
| CVRx (CVRX) | United States | $0.192B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.191B | 0.00 |
| Inogen (INGN) | United States | $0.180B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.179B | 0.00 |
| LENSAR (LNSR) | United States | $0.152B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.149B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.140B | 0.00 |
| Accuray (ARAY) | United States | $0.140B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.127B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.121B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.111B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.092B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.075B | 0.00 |
| InspireMD (NSPR) | United States | $0.072B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.071B | 43.20 |
| Spectral AI (MDAI) | United States | $0.068B | 0.00 |
| Hyperfine (HYPR) | United States | $0.062B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.056B | 0.00 |
| Covalon Technologies (CVALF) | Canada | $0.055B | 22.22 |
| Vicarious Surgical (RBOT) | United States | $0.054B | 0.00 |
| Precision Optics (POCI) | United States | $0.037B | 0.00 |
| Envoy Medical (COCH) | United States | $0.033B | 0.00 |
| DarioHealth (DRIO) | United States | $0.031B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.023B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.022B | 0.00 | |
| NexGel (NXGL) | United States | $0.020B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.018B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.011B | 0.00 |
| PAVmed (PAVM) | United States | $0.010B | 0.00 |
| Tenon Medical (TNON) | United States | $0.008B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.008B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.007B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.006B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.006B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.005B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.004B | 0.00 |
| Venus Concept (VERO) | Canada | $0.004B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.002B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.002B | 0.00 |
| Nuwellis (NUWE) | United States | $0.001B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $0.000B | 15.51 |